Ipsen
Piruntha Thiyagarajah is a highly experienced professional in the field of clinical development, currently serving as Senior Director at Ipsen since January 2025. Prior positions include Executive Director of Clinical Development at Immunocore from July 2023 to July 2024, and Global Clinical Program Lead and Senior Director Physician at AstraZeneca within the Late Oncology R&D division from June 2018 to June 2023. Thiyagarajah also contributed to The Janssen Pharmaceutical Companies of Johnson & Johnson as a Study Physician and Safety Physician from January 2011 to June 2018, and started a medical career at NHS between January 2006 and January 2011 as a Medical Doctor. Educational qualifications include a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Bart’s and the London Medical School and a BMedSci in Molecular Therapeutics from the William Harvey Research Institute.
This person is not in any teams
This person is not in any offices
Ipsen
22 followers
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease.